CHORIOMENINGITIS LYMPHOCYTIC

CHORIOMENINGITIS LYMPHOCYTIC was reported 69 times

CHORIOMENINGITIS LYMPHOCYTIC is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 16 0.0007
1 Antiprotozoal [EPC] 5 0.0005
2 Sulfone [EPC] 4 0.0004
3 CD52-directed Cytolytic Antibody [EPC] 4 0.0002
4 Human Immunoglobulin G [EPC] 3 0.0001
5 Antimetabolite Immunosuppressant [EPC] 3 0.0001
6 Polyene Antifungal [EPC] 5 0.0001
7 Lipopeptide Antibacterial [EPC] 1 0.0001
8 Purine Antimetabolite [EPC] 7 0.0001
9 Protease Inhibitor [EPC] 3 0.0001
10 Azole Antifungal [EPC] 10 0.0001
11 Calcineurin Inhibitor Immunosuppressant [EPC] 7 0.0001
12 Complement Inhibitor [EPC] 3 0.0001
13 Cytochrome P450 3A Inhibitor [EPC] 3 0.0000
14 Leukocyte Growth Factor [EPC] 4 0.0000
15 Nucleoside Analog Antiviral [EPC] 2 0.0000
16 Corticosteroid [EPC] 28 0.0000
17 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
18 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
19 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
20 Glycopeptide Antibacterial [EPC] 1 0.0000
21 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
22 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
23 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
24 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
25 Interferon beta [EPC] 1 0.0000
26 Alkylating Drug [EPC] 1 0.0000
27 Insulin Analog [EPC] 1 0.0000
28 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
29 Kinase Inhibitor [EPC] 1 0.0000
30 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000